Virginia Lyle King, Ph.D.
Dr. King (Virginia Lyle) is an Associate of Cure Ventures with over 10 years of research experience.
Individual strengths are amplified with teamwork, and our team is committed to improving patients' lives.
Dr. King (Virginia Lyle) is an Associate of Cure Ventures with over 10 years of research
experience. As a member of the Cure Ventures team, Lyle is involved in sourcing new deals,
conducting due diligence, and assisting with company creation endeavors.
Most recently, she worked at the University of Connecticut as a graduate researcher where she
gained extensive experience utilizing a broad range of genetic and molecular biology tools to
study the spatiotemporal regulation of cellular stress responses in relation to human diseases,
with a specific interest in cell death and cancer biology research. Her work established the actin
cytoskeleton and actin-binding proteins as essential regulators of cell death and identified the
importance of actin in coordinating the progression of apoptosis pathways. These discoveries
bridged a longstanding gap between the cytoskeleton and apoptosis fields and provided new
avenues for studying tumorigenesis. In addition to her academic research, Lyle cultivated
effective leadership experience by mentoring junior scientists, teaching multiple courses in
both laboratory and classroom settings, and volunteering for nonprofit educational programs
that work to address the communication gap that exists between the general public and
Lyle received her Ph.D. in Molecular and Cell Biology at the University of Connecticut in the
laboratory of Dr. Ken Campellone, and her B.S. in Biology at the University of Mary Washington.
Go back to our team